Intrinsic Value of S&P & Nasdaq Contact Us

Dyne Therapeutics, Inc. DYN NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
47/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$37.60
+89.8%

Dyne Therapeutics, Inc. (DYN) has 12 identified peers for comparison in the Healthcare sector. Peers include CGEM, CYTK, DICE, DSGN, ERAS, EWTX and others.

DYN has a market capitalization of $3.27B, compared to an average peer market cap of $5.51B.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message